Results 121 to 130 of about 11,211 (144)

Dolutegravir/abacavir/dolutegravir/lamivudine

Reactions Weekly, 2018
openaire   +1 more source

Implications of Efavirenz Pharmacogenetics When Switching From Efavirenz- to Dolutegravir-containing Antiretroviral Regimens.

Clinical Infectious Diseases, 2021
David W. Haas, Edward P Acosta
exaly  

Dolutegravir

Reactions Weekly, 2016
openaire   +2 more sources

Dolutegravir

Reactions Weekly, 2018
  +5 more sources

The risk of hyperglycemia associated with use of dolutegravir among adults living with HIV in Kampala, Uganda: A case-control study

International Journal of STD and AIDS, 2022
Willi McFarland, Daphine Namara
exaly  

Change in body weight and risk of hypertension after switching from efavirenz to dolutegravir in adults living with HIV: evidence from routine care in Johannesburg, South Africa

EClinicalMedicine, 2023
Matthew Patrick Fox, Willem Venter, Sydney Rosen   +2 more
exaly  

Pharmacokinetics and placental transfer of dolutegravir in pregnancy

Journal of Antimicrobial Chemotherapy, 2022
Dilly Anumba, Mushi Matjila
exaly  

Dolutegravir

Reactions Weekly, 2015
openaire   +1 more source

Virological Failure in HIV to Triple Therapy With Dolutegravir-Based Firstline Treatment: Rare but Possible.

Open Forum Infectious Diseases, 2019
Federico Garcia, Antonio D'Avolio, Natalia Chueca   +2 more
exaly  

Effects of boceprevir and telaprevir on the pharmacokinetics of dolutegravir

British Journal of Clinical Pharmacology, 2014
Julie Borland, Stephen C Piscitelli
exaly